RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

A wearable device for tremor

This small study tests an electronic device worn on the body to see how it affects shaking.

Testing a treatment or activity · Study reference: RBR-7ghhtqg

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Results reported

Start (reported date)
2026-02-01
Study finished (reported date)
2027-03-31

Planned dates can move. A study finishing does not tell us when a paper will be published.

Read the results reported in the registry

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 45y to 65y · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: -

Inclusion criteria: Diagnosis of idiopathic Parkinson's disease by a neurologist according to the criteria of the International Parkinson and Movement Disorders Society; Maintain stable treatment with dopaminergic medication, without planned changes in medication during the study; Be in stages I to III of the Hoehn & Yahr classification; Presence of classic parkinsonian tremor type 1 according to the consensus statement on tremor of the International Parkinson and Movement Disorders Society Exclusion criteria: Individuals with previously documented dementia or a score of 22 or lower on the Montreal Cognitive Assessment; Individuals with other associated neurological diseases, specifically those that also present with tremor, such as essential tremor and peripheral neuropathies; Individuals with mild to severe sensory impairments that make their response to sensory stimulation unpredictable, measured with a graduated tuning fork, will be excluded with an average score of 5.9 or lower on the wrist; Presence of dyskinesias; Deep brain stimulation implant, or other conditions that prevent participation in the study procedures.
Full study name & original research details

Official study title

Wearable electronic device for tremor mitigation in Parkinson's disease: a feasibility study

Short title used by the registry

Wearable electronic device for reducing tremor in Parkinson's disease

Original description

Intervention: This is a randomized, double-blind, placebo-controlled, crossover clinical trial. It will involve 18 individuals of both sexes, aged 45 to 65 years, diagnosed with idiopathic Parkinson's disease (Hoehn & Yahr stages I to III) and presenting with classic type I tremor. Participants will undergo three intervention conditions: two vibration frequencies, high and low frequency, and a placebo condition (no vibration) applied to the forearm of the limb with the greatest tremor in each participant. The sessions will occur in a single session for each vibrational stimulation frequency, with their order randomized, and will also have a washout period of at least 48 hours between them, taking place during the off-period of dopaminergic medication Primary outcome: It is expected that participants will experience a greater reduction in the severity of Parkinsonian tremor when subjected to high-frequency vibration intervention compared to low-frequency vibration and placebo (no vibration) Secondary outcome: It is expected that individuals subjected to high-frequency vibration will show improved performance on manual dexterity tests such as the Nine Hole Peg Test and the Box and Block Test compared to those subjected to low-frequency vibration and placebo (no vibration)

Conditions reported: Parkinson Disease; Tremor Nervous System Diseases

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
This is a randomized, double-blind, placebo-controlled, crossover clinical trial. It will involve 18 individuals of both sexes, aged 45 to 65 years, diagnosed with idiopathic Parkinson's disease (Hoehn & Yahr stages I to III) and presenting with classic type I tremor. Participants will undergo three intervention conditions: two vibration frequencies, high and low frequency, and a placebo condition (no vibration) applied to the forearm of the limb with the greatest tremor in each participant. The sessions will occur in a single session for each vibrational stimulation frequency, with their order randomized, and will also have a washout period of at least 48 hours between them, taking place during the off-period of dopaminergic medication
Phases
N/A
Sponsor
Decanato de Pesquisa e Inovação e Parque Científico e Tecnológico - Universidade de Brasília
Start date reported by registry
2026-02-01 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Vítor Eduardo Weprajetzky · +55(61)984115841 · vitorweprajetzky@gmail.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

BR

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.